ORAL product line
| ACAMPROSATE CALCIUM | Midodrine (outside USA) |
| Clindamycin HCl USP/PhEur |
Nateglinide |
| DOXERCALCIFEROL | Ondansetron USP** |
| Ethosuximide USP | Procarbazine HCl |
| Granisetron HCl | Sirolimus** |
| HYDROXYCHLOROQUINE SULFATE | Tacrolimus |
| Isradipine USP | tiagabine hydrochloride |
| Lovastatin USP | Tizanidine HCl USP |
| Medroxyprogesterone Acetate USP | Topiramate** |
Items denoted by blue text have been approved in the USA/EC
** Pending Approval
chemwerth's goal is to offer the best source – not the first source. Using chemwerth's APIs, you will receive the fastest FDA approval possible which is critical to your success in the highly competitive generic oral market. Our Regulatory expertise allows for customers to receive FDA approval in 12 to 15 months.
E-Mail: chemwerth@chemwerth.com
